Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis

Clinical trial NCT01755507 · COMPLETED

Trial details

NCT number: NCT01755507
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Sclerosing Cholangitis

Start date: 2012-12-01
Primary completion: 2015-10-01
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.